Expiration Date: 12/23/2018
The landscape of genetic testing and treatment for inherited retinal diseases (IRDs) is rapidly evolving. Keeping up-to-date on clinical trials, ordering and…go to activity»
This activity is supported by an educational grant from Bausch + Lomb.
Expiration Date: 12/26/2018
Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people affected by the condition. With the aging population, it is…go to activity»
This educational activity is supported by an independent medical educational grant from Shire.
Expiration Date: 12/20/2018
Dry eye disease (DED) is a multifactorial disorder of the ocular surface, with nearly 30 million adults in the United States reporting symptoms. Despite its high…go to activity»
This activity is supported by educational grants from Aerie Pharmaceuticals, Inc.; Alcon Laboratories, Inc.; Bausch + Lomb; Glaukos Corporation; and Novartis Pharmaceuticals Corporation.
Expiration Date: 12/19/2018
Incisional glaucoma surgery has traditionally been reserved for patients with progressive disease, and in whom medical and laser therapies have been exhausted…go to activity»
This activity is supported by educational grants from Abbott Medical Optics, Inc.; Alcon Laboratories, Inc.; and Carl Zeiss Meditec, Inc.
Expiration Date: 10/9/2018
Successful cataract surgery involves a multifactorial process that relies on numerous interconnected assessment, planning, and execution procedures. Phacodynamics, which…go to activity»
This activity is produced by SLACK Incorporated and sponsored by TearScience, Inc. Participating physicians are paid consultants of TearScience, Inc.
November 8, 2017
This roundtable discussion highlights the importance of treating MGD before ocular surgery to improve patient outcomes. Faculty members discuss the implications of…go to activity»